View in EDS HTML Full Text PDF Full Text

Efficacy of ibrutinib as salvage treatment in a secondary central nervous system lymphoma (SCNSL) progressed after chemorefractory Primary Mediastinal B Cell Lymphoma (PMBCL).

Saved in:
Bibliographic Details
Title: Efficacy of ibrutinib as salvage treatment in a secondary central nervous system lymphoma (SCNSL) progressed after chemorefractory Primary Mediastinal B Cell Lymphoma (PMBCL).
Authors: Malfona F; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Testi AM; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Moleti ML; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Petrucci L; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Leccisotti L; Nuclear Medicine Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome., Martelli M; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Di Rocco A; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
Source: Leukemia & lymphoma [Leuk Lymphoma] 2022 Feb; Vol. 63 (2), pp. 483-486. Date of Electronic Publication: 2021 Oct 06.
Publication Type: Letter
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34612154
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy of ibrutinib as salvage treatment in a secondary central nervous system lymphoma (SCNSL) progressed after chemorefractory Primary Mediastinal B Cell Lymphoma (PMBCL).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Malfona+F%22">Malfona F</searchLink>; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Testi+AM%22">Testi AM</searchLink>; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Moleti+ML%22">Moleti ML</searchLink>; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Petrucci+L%22">Petrucci L</searchLink>; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Leccisotti+L%22">Leccisotti L</searchLink>; Nuclear Medicine Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome.<br /><searchLink fieldCode="AU" term="%22Martelli+M%22">Martelli M</searchLink>; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Di+Rocco+A%22">Di Rocco A</searchLink>; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229007422%22">Leukemia & lymphoma</searchLink> [Leuk Lymphoma] 2022 Feb; Vol. 63 (2), pp. 483-486. <i>Date of Electronic Publication: </i>2021 Oct 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9007422 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1029-2403 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210268022%22">10268022 </searchLink><i>NLM ISO Abbreviation: </i>Leuk Lymphoma <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34612154
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/10428194.2021.1978091
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 483
    Titles:
      – TitleFull: Efficacy of ibrutinib as salvage treatment in a secondary central nervous system lymphoma (SCNSL) progressed after chemorefractory Primary Mediastinal B Cell Lymphoma (PMBCL).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Malfona F
      – PersonEntity:
          Name:
            NameFull: Testi AM
      – PersonEntity:
          Name:
            NameFull: Moleti ML
      – PersonEntity:
          Name:
            NameFull: Petrucci L
      – PersonEntity:
          Name:
            NameFull: Leccisotti L
      – PersonEntity:
          Name:
            NameFull: Martelli M
      – PersonEntity:
          Name:
            NameFull: Di Rocco A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2022 Feb
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1029-2403
          Numbering:
            – Type: volume
              Value: 63
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Leukemia & lymphoma
              Type: main
ResultId 1